Journal Article

Pre-diagnosis and pre-treatment loss to follow-up and associated factors among patients with presumed tuberculosis and those diagnosed in Uganda

Kiwanuka, Noah, Nakanjako, Lydia, Luzze, Henry, Atuyambe, Lynn, Buregyeya, Esther, Wafula, Solomon T., Turyahabwe, Stavia, Sekandi, Juliet N., Nuwematsiko, Rebecca, Nakafeero, Mary

2024

Overview

Background Loss to follow-up (LTFU) of patients with presumed tuberculosis (TB) before completing the diagnostic process (pre-diagnosis LTFU) and before initiating treatment for those diagnosed (pre-treatment LTFU) is a challenge in the realization of the End TB Strategy. We assessed the proportion of pre-diagnosis and pre-treatment LTFU and associated factors among patients with presumed TB and those diagnosed in the selected health facilities. Methods This was a retrospective cohort study involving a review of routinely collected data from presumptive, laboratory and TB treatment registers from January 2019 to December 2022. The study was conducted in three general hospitals and one lower-level health center IV in Central Uganda. We defined pre-diagnosis LTFU as failure to test for TB and obtain results within 30 days from the date of being presumed and pre-treatment LTFU as failure to initiate TB treatment within 14 days from the date of diagnosis. Modified Poisson regression was used to estimate prevalence ratios (PRs) and 95% confidence intervals (CIs) of factors associated with pre-diagnosis and pre-treatment LTFU. Results Of the 13,064 patients with presumed TB, 39.9% were aged 25 to 44 years, and 57.1% were females. Almost a third, 28.3% (3,699/13.064) experienced pre-diagnosis LTFU and 13.7% (163/1187) did not initiate treatment within 14 days from being diagnosed. Pre-diagnosis LTFU was more likely to occur among patients aged 0-14 years (adj PR 1.1, 95% CI: 1.06,1.24), females (adj.PR=1.06, 95% CI: 1.01, 1.12) and those with no record of place of residence (adj. PR=2.7, 95% CI: 2.54, 2.93). In addition, patients with no record of phone contact were more likely to be LTFU, (adj. PR=1.1, 95% CI: 1.05, 1.17). Pre-treatment LTFU was also more likely among patients with no record of place of residence (adj PR 7.1, 95% CI: 5.13,9.85) and those with no record of phone contact (adj PR 2.2, 95% CI: 1.63,2.86). Patients presumed from the HIV clinics were 40% less likely to experience pre-treatment LTFU compared to those in the outpatient departments (adj PR 0.6, 95% CI: 0.41,0.88). Conclusion High proportions of pre-diagnosis and pre-treatment LTFU were observed in this study. This calls for urgent interventions at these time points in the TB care cascade to be able to realise the End TB Strategy.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Adolescent / Adult / Care and treatment / Child / Child, Preschool / COVID-19 / Data collection / Demographic aspects / Diagnosis / Diagnosis loss to follow / Disease transmission / Female / Health Administration / Health facilities / Health Informatics / HIV / Human immunodeficiency virus / Humans / Infant / Laboratories / Lost to Follow-Up / Male / Medical diagnosis / Medicine / Medicine & Public Health / Microscopy / Middle Aged / Nursing Research / Pandemics / Patients rights / Public Health / Retrospective Studies / Treatment loss to follow / Tuberculosis / Tuberculosis - diagnosis / Tuberculosis - drug therapy / Tuberculosis - epidemiology / Tuberculosis, loss to follow / Uganda - epidemiology / Up, pre / Up, Uganda / Young Adult